CUREVAC NV (1CVAC.MI) Fundamental Analysis & Valuation

BIT:1CVAC • NL0015436031

4.386 EUR
-0.22 (-4.82%)
Last: Dec 11, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1CVAC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, 1CVAC scores 4 out of 10 in our fundamental rating. 1CVAC was compared to 75 industry peers in the Biotechnology industry. Both the profitability and the financial health of 1CVAC get a neutral evaluation. Nothing too spectacular is happening here. 1CVAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. 1CVAC.MI Profitability Analysis

1.1 Basic Checks

  • 1CVAC had positive earnings in the past year.
  • In the past year 1CVAC has reported a negative cash flow from operations.
  • 1CVAC had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: 1CVAC reported negative operating cash flow in multiple years.
1CVAC.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVAC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M

1.2 Ratios

  • The Return On Assets of 1CVAC (11.31%) is better than 83.13% of its industry peers.
  • 1CVAC has a better Return On Equity (14.79%) than 81.93% of its industry peers.
  • With an excellent Return On Invested Capital value of 14.12%, 1CVAC belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
Industry RankSector Rank
ROA 11.31%
ROE 14.79%
ROIC 14.12%
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
1CVAC.MI Yearly ROA, ROE, ROIC1CVAC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • Looking at the Profit Margin, with a value of 182.11%, 1CVAC belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
  • With an excellent Operating Margin value of 212.01%, 1CVAC belongs to the best of the industry, outperforming 97.59% of the companies in the same industry.
  • The Gross Margin of 1CVAC (93.01%) is better than 87.95% of its industry peers.
Industry RankSector Rank
OM 212.01%
PM (TTM) 182.11%
GM 93.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1CVAC.MI Yearly Profit, Operating, Gross Margins1CVAC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1CVAC.MI Health Analysis

2.1 Basic Checks

  • 1CVAC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1CVAC remains at a similar level compared to 1 year ago.
  • 1CVAC has more shares outstanding than it did 5 years ago.
  • 1CVAC has a better debt/assets ratio than last year.
1CVAC.MI Yearly Shares Outstanding1CVAC.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
1CVAC.MI Yearly Total Debt VS Total Assets1CVAC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • 1CVAC has an Altman-Z score of 4.42. This indicates that 1CVAC is financially healthy and has little risk of bankruptcy at the moment.
  • 1CVAC's Altman-Z score of 4.42 is fine compared to the rest of the industry. 1CVAC outperforms 78.31% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that 1CVAC is not too dependend on debt financing.
  • The Debt to Equity ratio of 1CVAC (0.03) is better than 69.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACC1.97
WACC7.16%
1CVAC.MI Yearly LT Debt VS Equity VS FCF1CVAC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • 1CVAC has a Current Ratio of 3.70. This indicates that 1CVAC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.70, 1CVAC is in the better half of the industry, outperforming 68.67% of the companies in the same industry.
  • 1CVAC has a Quick Ratio of 3.69. This indicates that 1CVAC is financially healthy and has no problem in meeting its short term obligations.
  • 1CVAC's Quick ratio of 3.69 is fine compared to the rest of the industry. 1CVAC outperforms 73.49% of its industry peers.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.69
1CVAC.MI Yearly Current Assets VS Current Liabilites1CVAC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1CVAC.MI Growth Analysis

3.1 Past

  • 1CVAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.83%, which is quite impressive.
  • 1CVAC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -86.98%.
  • The Revenue has been growing by 98.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.33%
Revenue 1Y (TTM)-86.98%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-89.41%

3.2 Future

  • Based on estimates for the next years, 1CVAC will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.50% on average per year.
  • 1CVAC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.88% yearly.
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-10.88%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CVAC.MI Yearly Revenue VS Estimates1CVAC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
1CVAC.MI Yearly EPS VS Estimates1CVAC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1CVAC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1CVAC is valuated cheaply with a Price/Earnings ratio of 7.56.
  • 93.98% of the companies in the same industry are more expensive than 1CVAC, based on the Price/Earnings ratio.
  • 1CVAC is valuated cheaply when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • 1CVAC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 7.56
Fwd PE N/A
1CVAC.MI Price Earnings VS Forward Price Earnings1CVAC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 91.57% of the companies in the same industry are more expensive than 1CVAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.58
1CVAC.MI Per share data1CVAC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as 1CVAC's earnings are expected to decrease with -28.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1CVAC.MI Dividend Analysis

5.1 Amount

  • 1CVAC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1CVAC.MI Fundamentals: All Metrics, Ratios and Statistics

CUREVAC NV

BIT:1CVAC (12/11/2025, 7:00:00 PM)

4.386

-0.22 (-4.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-24
Earnings (Next)04-08
Inst Owners10.45%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap987.60M
Revenue(TTM)70.74M
Net Income(TTM)128.82M
Analysts73.33
Price Target4.03 (-8.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)557.4%
Min EPS beat(2)-39.67%
Max EPS beat(2)1154.47%
EPS beat(4)2
Avg EPS beat(4)282.88%
Min EPS beat(4)-39.67%
Max EPS beat(4)1154.47%
EPS beat(8)3
Avg EPS beat(8)141.82%
EPS beat(12)5
Avg EPS beat(12)87.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)149.77%
Min Revenue beat(2)-96.47%
Max Revenue beat(2)396.01%
Revenue beat(4)2
Avg Revenue beat(4)82.72%
Min Revenue beat(4)-96.47%
Max Revenue beat(4)396.01%
Revenue beat(8)5
Avg Revenue beat(8)105.08%
Revenue beat(12)5
Avg Revenue beat(12)59.37%
Revenue beat(16)8
Avg Revenue beat(16)72.27%
PT rev (1m)-3.19%
PT rev (3m)-4.52%
EPS NQ rev (1m)966.6%
EPS NQ rev (3m)404.74%
EPS NY rev (1m)-7.12%
EPS NY rev (3m)-7.12%
Revenue NQ rev (1m)33.33%
Revenue NQ rev (3m)34.82%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)-13.75%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE N/A
P/S 13.96
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.17
EV/EBITDA 3.58
EPS(TTM)0.58
EY13.22%
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.31
BVpS3.87
TBVpS3.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.11
Profitability
Industry RankSector Rank
ROA 11.31%
ROE 14.79%
ROCE 16.62%
ROIC 14.12%
ROICexc 26.37%
ROICexgc 27.79%
OM 212.01%
PM (TTM) 182.11%
GM 93.01%
FCFM N/A
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.18
Cap/Depr 28.09%
Cap/Sales 7.01%
Interest Coverage 66.45
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.69
Altman-Z 4.42
F-Score3
WACC7.16%
ROIC/WACC1.97
Cap/Depr(3y)242.45%
Cap/Depr(5y)397%
Cap/Sales(3y)81.47%
Cap/Sales(5y)93.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.33%
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue 1Y (TTM)-86.98%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-89.41%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-10.88%
EBIT growth 1Y13.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-158.29%
EBIT Next 3Y-29.43%
EBIT Next 5YN/A
FCF growth 1Y62.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.06%
OCF growth 3YN/A
OCF growth 5YN/A

CUREVAC NV / 1CVAC.MI FAQ

What is the ChartMill fundamental rating of CUREVAC NV (1CVAC.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1CVAC.MI.


Can you provide the valuation status for CUREVAC NV?

ChartMill assigns a valuation rating of 5 / 10 to CUREVAC NV (1CVAC.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for CUREVAC NV?

CUREVAC NV (1CVAC.MI) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CUREVAC NV (1CVAC.MI) stock?

The Price/Earnings (PE) ratio for CUREVAC NV (1CVAC.MI) is 7.56 and the Price/Book (PB) ratio is 1.13.